The influence of MAP2K1/2 mutations on the expression of immunity-related genes was also evaluated by analysing the RNA expression profile data collected from these cohorts and from the Cancer Genome Atlas (TCGA) melanoma cohort. The gene discussed is MAP2K1; the disease is melanoma.